Jump to ContentJump to Main Navigation
SchizophreniaEvolution and Synthesis$
Users without a subscription are not able to see the full content.

Steven M. Silverstein, Bita Moghaddam, and Til Wykes

Print publication date: 2013

Print ISBN-13: 9780262019620

Published to MIT Press Scholarship Online: May 2014

DOI: 10.7551/mitpress/9780262019620.001.0001

Show Summary Details
Page of

PRINTED FROM MIT PRESS SCHOLARSHIP ONLINE (www.mitpress.universitypressscholarship.com). (c) Copyright The MIT Press, 2022. All Rights Reserved. An individual user may print out a PDF of a single chapter of a monograph in MITSO for personal use.date: 29 June 2022

How the Diagnosis of Schizophrenia Impeded the Advance of Knowledge (and What to Do About It)

How the Diagnosis of Schizophrenia Impeded the Advance of Knowledge (and What to Do About It)

Chapter:
(p.49) 3 How the Diagnosis of Schizophrenia Impeded the Advance of Knowledge (and What to Do About It)
Source:
Schizophrenia
Author(s):

William T. Carpenter

Publisher:
The MIT Press
DOI:10.7551/mitpress/9780262019620.003.0003

Schizophrenia is best viewed as a clinical syndrome, without compelling evidence of a homogeneous disease. Most investigations over the past century, however, have been designed without addressing heterogeneity, thus impeding knowledge acquisition. Recent paradigm shifts in the schizophrenia construct are intended to provide more valid and more robust approaches to discovery. These include: 1) Identifying patient subgroups to enrich study cohort homogeneity on causal pathway and pathophysiology; 2) Identifying key domains of psychopathology and using each domain as the pathology of interest; 3) Investigating molecules, genes, and pathways related to known neural circuits and behavioral constructs which, in turn, are related to psychopathology domains; and 4) Using stages of vulnerability development as study targets, to conceptualize causal pathways to early vulnerability that are not specific to schizophrenia, as well as later stages associated with pathological variables which have greater disorder-outcome specificity. The first paradigm shift can be informative for a form of schizophrenia that may not generalize to all forms of the disorder. The last three provide for more specific study targets but address pathologies that will cut across current disorder boundaries. The fourth paradigm, in particular, calls attention to preventive and resiliency factors as well as causal factors. Published in the Strungmann Forum Reports Series.

Keywords:   Schizophrenia, Heterogeneity, Psychopathology, Pathophysiology, Neuroscience, Vulnerability, Prevention, Resilience, Paradigm, Research Domain Criteria

MIT Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.